{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T17:24:17Z","timestamp":1769189057942,"version":"3.49.0"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Type 1 diabetes mellitus (T1DM) is an autoimmune disorder specifically targeting pancreatic islet beta cells. Despite many efforts focused on identifying new therapies able to counteract this autoimmune attack and\/or stimulate beta cells regeneration, TD1M remains without effective clinical treatments providing no clear advantages over the conventional treatment with insulin. We previously postulated that both the inflammatory and immune responses and beta cell survival\/regeneration must be simultaneously targeted to blunt the progression of disease. Umbilical cord-derived mesenchymal stromal cells (UC-MSC) exhibit anti-inflammatory, trophic, immunomodulatory and regenerative properties and have shown some beneficial yet controversial effects in clinical trials for T1DM. In order to clarify conflicting results, we herein dissected the cellular and molecular events derived from UC-MSC intraperitoneal administration (i.p.) in the RIP-B7.1 mouse model of experimental autoimmune diabetes. Intraperitoneal (i.p.) transplantation of heterologous mouse UC-MSC delayed the onset of diabetes in RIP-B7.1 mice. Importantly, UC-MSC i. p. transplantation led to a strong peritoneal recruitment of myeloid-derived suppressor cells (MDSC) followed by multiple T-, B- and myeloid cells immunosuppressive responses in peritoneal fluid cells, spleen, pancreatic lymph nodes and the pancreas, which displayed significantly reduced insulitis and pancreatic infiltration of T and B Cells and pro-inflammatory macrophages. Altogether, these results suggest that UC-MSC i. p. transplantation can block or delay the development of hyperglycemia through suppression of inflammation and the immune attack.<\/jats:p>","DOI":"10.3389\/fcell.2023.1089817","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T12:25:42Z","timestamp":1676463942000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses"],"prefix":"10.3389","volume":"11","author":[{"given":"C. C.","family":"Lachaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Cobo-Vuilleumier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fuente-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"Cahuana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Tejedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hmadcha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. R.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1055\/s-0043-109000","article-title":"Environmental risk factors for type 1 diabetes mellitus development","volume":"125","author":"Antonela","year":"2017","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/cmi.2013.39","article-title":"Macrophage polarization in response to wear particles in vitro","volume":"10","author":"Antonios","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.2337\/dc13-0327","article-title":"Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: Results of the randomized phase III study in recent-onset human type 1 diabetes","volume":"37","author":"Aronson","year":"2014","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1089\/scd.2005.14.252","article-title":"Immunogenicity of adult mesenchymal stem cells: Lessons from the fetal allograft","volume":"14","author":"Barry","year":"2005","journal-title":"Stem Cells Dev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.4049\/jimmunol.2001127","article-title":"Regulatory B cells in autoimmune diabetes","volume":"206","author":"Ben Nasr","year":"2021","journal-title":"J. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13287-017-0742-8","article-title":"Immunoprivileged no more: Measuring the immunogenicity of allogeneic adult mesenchymal stem cells","volume":"8","author":"Berglund","year":"2017","journal-title":"Stem Cell. Res. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/11024159950189780","article-title":"Intraperitoneal transplantation of isologous mesothelial cells for prevention of adhesions","volume":"165","author":"Bertram","year":"1999","journal-title":"Eur. J. Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nature08933","article-title":"Genetics, pathogenesis and clinical interventions in type 1 diabetes","volume":"464","author":"Bluestone","year":"2010","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: A regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.4049\/jimmunol.159.10.4686","article-title":"IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function","volume":"159","author":"Cameron","year":"1997","journal-title":"J. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/db15-0779","article-title":"Insulitis and beta-cell mass in the natural history of type 1 diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.jcyt.2017.08.004","article-title":"Umbilical cord mesenchymal stromal cell transplantations: A systemic analysis of clinical trials","volume":"19","author":"Can","year":"2017","journal-title":"Cytotherapy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijpharm.2018.03.041","article-title":"Current advanced therapy cell-based medicinal products for type-1-diabetes treatment","volume":"543","author":"Canibano-Hernandez","year":"2018","journal-title":"Int. J. Pharm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fimmu.2015.00225","article-title":"Revisiting mouse peritoneal macrophages: Heterogeneity, development, and function","volume":"6","author":"Cassado Ados","year":"2015","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/cmi.2016.59","article-title":"Mesenchymal stem cells ameliorate B-cell-mediated immune responses and increase IL-10-expressing regulatory B cells in an EBI3-dependent manner","volume":"14","author":"Cho","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.2337\/dbi16-0008","article-title":"Delving into the type 1 diabetic islet: Evidence that B-cell infiltration of islets is linked to local hyperimmunity and accelerated progression to disease","volume":"65","author":"Christie","year":"2016","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"154137","DOI":"10.1016\/j.metabol.2020.154137","article-title":"Time for a paradigm shift in treating type 1 diabetes mellitus: Coupling inflammation to islet regeneration","volume":"104","author":"Cobo-Vuilleumier","year":"2020","journal-title":"Metabolism"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/s41467-018-03943-0","article-title":"LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus","volume":"9","author":"Cobo-Vuilleumier","year":"2018","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00125-019-4942-x","article-title":"Early-life factors contributing to type 1 diabetes","volume":"62","author":"Craig","year":"2019","journal-title":"Diabetologia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jneuroim.2014.02.003","article-title":"New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids","volume":"270","author":"de Andres","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.diabres.2016.09.008","article-title":"Intravenous vs intraperitoneal transplantation of umbilical cord mesenchymal stem cells from Wharton's jelly in the treatment of streptozotocin-induced diabetic rats","volume":"121","author":"El-Hossary","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/sji.12253","article-title":"Peritoneal cavity is a route for gut-derived microbial signals to promote autoimmunity in non-obese diabetic mice","volume":"81","author":"Emani","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1084\/jem.20170074","article-title":"The islet-resident macrophage is in an inflammatory state and senses microbial products in blood","volume":"214","author":"Ferris","year":"2017","journal-title":"J. Exp. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2012.00212","article-title":"Immunomodulatory effect of mesenchymal stem cells on B cells","volume":"3","author":"Franquesa","year":"2012","journal-title":"Front. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ni.2233","article-title":"Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging","volume":"13","author":"Fu","year":"2012","journal-title":"Nat. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1172\/JCI44339","article-title":"Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients","volume":"121","author":"Gaglia","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/pedi.12072","article-title":"Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: A non-randomized, controlled trial","volume":"15","author":"Giannopoulou","year":"2014","journal-title":"Pediatr. Diabetes"},{"key":"B30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"670","DOI":"10.4049\/jimmunol.1203211","article-title":"IL-4 upregulates Ig\u03b1 and Ig\u03b2 protein, resulting in augmented IgM maturation and B cell receptor-triggered B cell activation","volume":"191","author":"Guo","year":"2013","journal-title":"J. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.2337\/dc11-1406","article-title":"Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide","volume":"34","author":"Haller","year":"2011","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.humimm.2019.05.011","article-title":"Immunomodulation of human CD19(+)CD25(high) regulatory B cells via Th17\/Foxp3 regulatory T cells and Th1\/Th2 cytokines","volume":"80","author":"Hong","year":"2019","journal-title":"Hum. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1507\/endocrj.ej12-0343","article-title":"Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus","volume":"60","author":"Hu","year":"2013","journal-title":"Endocr. J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11892-017-0916-x","article-title":"The role of epigenetics in type 1 diabetes","volume":"17","author":"Jerram","year":"2017","journal-title":"Curr. Diab Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/eji.200324744","article-title":"Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice","volume":"34","author":"Kendall","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","article-title":"Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells","volume":"11","author":"Kessel","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/08923973.2015.1085065","article-title":"Cucurbitacin B inhibits immunomodulatory function and the inflammatory response in macrophages","volume":"37","author":"Kim","year":"2015","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2337\/db13-1639","article-title":"Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens","volume":"64","author":"Kleffel","year":"2015","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0187455","DOI":"10.1371\/journal.pone.0187455","article-title":"MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset","volume":"12","author":"Korf","year":"2017","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fimmu.2011.00057","article-title":"Modulation of macrophage efferocytosis in inflammation","volume":"2","author":"Korns","year":"2011","journal-title":"Front. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e1304","DOI":"10.1038\/cddis.2014.271","article-title":"EGF-induced adipose tissue mesothelial cells undergo functional vascular smooth muscle differentiation","volume":"5","author":"Lachaud","year":"2014","journal-title":"Cell. Death Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3109\/14653240903121278","article-title":"Microencapsulated UCB cells repair hepatic injure by intraperitoneal transplantation","volume":"11","author":"Li","year":"2009","journal-title":"Cytotherapy"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/JLB.3MA0821-029R","article-title":"Polymorphonuclear myeloid-derived suppressor cells link inflammation and damage response after trauma","volume":"110","author":"Li","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"15672","DOI":"10.1038\/srep15672","article-title":"PAX4 defines an expandable beta-cell subpopulation in the adult pancreatic islet","volume":"5","author":"Lorenzo","year":"2015","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13287-021-02417-3","article-title":"One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: An open parallel controlled clinical study","volume":"12","author":"Lu","year":"2021","journal-title":"Stem Cell. Res. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3389\/fimmu.2017.01042","article-title":"Inflammatory conditions dictate the effect of mesenchymal stem or stromal cells on B cell function","volume":"8","author":"Luk","year":"2017","journal-title":"Front. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc12-0038","article-title":"Administration of CD4+CD25highCD127-regulatory T cells preserves beta-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00125-016-3864-0","article-title":"PAX4 preserves endoplasmic reticulum integrity preventing beta cell degeneration in a mouse model of type 1 diabetes mellitus","volume":"59","author":"Mellado-Gil","year":"2016","journal-title":"Diabetologia"},{"key":"B50","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/iub.1330","article-title":"Islet inflammation in human type 1 diabetes mellitus","volume":"66","author":"Morgan","year":"2014","journal-title":"IUBMB Life"},{"key":"B51","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1476-5381.2009.00291.x","article-title":"Arginase: An emerging key player in the mammalian immune system","volume":"158","author":"Munder","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1158\/0008-5472.CAN-09-2152","article-title":"Regulatory myeloid suppressor cells in health and disease","volume":"69","author":"Nagaraj","year":"2009","journal-title":"Cancer Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S2213-8587(19)30412-7","article-title":"Type 1 diabetes-early life origins and changing epidemiology","volume":"8","author":"Norris","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","article-title":"Verapamil and beta cell function in adults with recent-onset type 1 diabetes","volume":"24","author":"Ovalle","year":"2018","journal-title":"Nat. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12950-017-0151-x","article-title":"Higher phagocytic activity of thioglycollate-elicited peritoneal macrophages is related to metabolic status of the cells","volume":"14","author":"Pavlou","year":"2017","journal-title":"J. Inflamm. (Lond)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3389\/fimmu.2017.01279","article-title":"Clinical tolerogenic dendritic cells: Exploring therapeutic impact on human autoimmune disease","volume":"8","author":"Phillips","year":"2017","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fimmu.2019.00148","article-title":"Tolerogenic dendritic cells and T-regulatory cells at the clinical trials crossroad for the treatment of autoimmune disease; emphasis on type 1 diabetes therapy","volume":"10","author":"Phillips","year":"2019","journal-title":"Front. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","article-title":"Genetic risk factors for type 1 diabetes","volume":"387","author":"Pociot","year":"2016","journal-title":"Lancet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e12678","DOI":"10.1111\/xen.12678","article-title":"Potential roles of mesenchymal stromal cells in islet allo- and xenotransplantation for type 1 diabetes mellitus","volume":"28","author":"Qu","year":"2021","journal-title":"Xenotransplantation"},{"key":"B60","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1196\/annals.1337.034","article-title":"Experimental autoimmune diabetes: A new tool to study mechanisms and consequences of insulin-specific autoimmunity","volume":"1037","author":"Rajasalu","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.2337\/db09-1135","article-title":"Deficiency in B7-H1 (PD-L1)\/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells","volume":"59","author":"Rajasalu","year":"2010","journal-title":"Diabetes"},{"key":"B62","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fimmu.2014.00532","article-title":"Metabolism via arginase or nitric oxide synthase: Two competing arginine pathways in macrophages","volume":"5","author":"Rath","year":"2014","journal-title":"Front. Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3791\/1488","article-title":"Isolation of mouse peritoneal cavity cells","volume":"35","author":"Ray","year":"2010","journal-title":"J. Vis. Exp."},{"key":"B64","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the beta-cell (do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jnc.12135","article-title":"Ly6C+ Ly6G- Myeloid-derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury","volume":"125","author":"Saiwai","year":"2013","journal-title":"J. Neurochem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"7053963","DOI":"10.1155\/2016\/7053963","article-title":"Altered macrophage and dendritic cell response in mif-\/- mice reveals a role of mif for inflammatory-Th1 response in type 1 diabetes","volume":"2016","author":"Sanchez-Zamora","year":"2016","journal-title":"J. Diabetes Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2013.12.003","article-title":"CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes","volume":"50","author":"Sarikonda","year":"2014","journal-title":"J. Autoimmun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/eji.201040801","article-title":"Saturated-efferocytosis generates pro-resolving CD11b low macrophages: Modulation by resolvins and glucocorticoids","volume":"41","author":"Schif-Zuck","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"749192","DOI":"10.3389\/fimmu.2021.749192","article-title":"Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases","volume":"12","author":"Shen","year":"2021","journal-title":"Front. Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tem.2006.03.006","article-title":"B cells in the spotlight: Innocent bystanders or major players in the pathogenesis of type 1 diabetes","volume":"17","author":"Silveira","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.2174\/1381612823666170214120708","article-title":"Cell-based tolerogenic therapy, experience from animal models of multiple sclerosis, type 1 diabetes and rheumatoid arthritis","volume":"23","author":"Stojanovic","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"B72","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/jcp.21346","article-title":"Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus","volume":"215","author":"Stosic-Grujicic","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ecl.2010.05.001","article-title":"Use of nonobese diabetic mice to understand human type 1 diabetes","volume":"39","author":"Thayer","year":"2010","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00125-021-05398-3","article-title":"Current and future therapies for type 1 diabetes","volume":"64","author":"von Scholten","year":"2021","journal-title":"Diabetologia"},{"key":"B75","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1517\/14712598.2014.881797","article-title":"Treatment of new onset type 1 diabetes with teplizumab: Successes and pitfalls in development","volume":"14","author":"Vudattu","year":"2014","journal-title":"Expert Opin. Biol. Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s40620-014-0133-5","article-title":"Adipose-derived mesenchymal stem cells transplantation facilitate experimental peritoneal fibrosis repair by suppressing epithelial-mesenchymal transition","volume":"27","author":"Wakabayashi","year":"2014","journal-title":"J. Nephrol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"798320","DOI":"10.3389\/fphar.2021.798320","article-title":"Emerging roles of myeloid-derived suppressor cells in diabetes","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","article-title":"New frontiers in the treatment of type 1 diabetes","volume":"31","author":"Warshauer","year":"2020","journal-title":"Cell. Metab."},{"key":"B79","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/eji.201141770","article-title":"Abnormalities of dendritic cell precursors in the pancreas of the NOD mouse model of diabetes","volume":"42","author":"Welzen-Coppens","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","article-title":"Analysis of islet inflammation in human type 1 diabetes","volume":"155","author":"Willcox","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri3831","article-title":"Type 2 cytokines: Mechanisms and therapeutic strategies","volume":"15","author":"Wynn","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3389\/fimmu.2017.01508","article-title":"Interleukin-4 supports the suppressive immune responses elicited by regulatory T cells","volume":"8","author":"Yang","year":"2017","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1089817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T12:25:46Z","timestamp":1676463946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1089817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":82,"alternative-id":["10.3389\/fcell.2023.1089817"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2023.1089817","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"article-number":"1089817"}}